Takuya Osada

6.9k citations

117 papers · 5.5k indexed · 1 hit paper · h-index 42

Immunology top 1%
- Immunotherapy and Immune Responses 42
- Immune Cell Function and Interaction 20
- T-cell and B-cell Immunology 14
Oncology top 1%
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 12
- HER2/EGFR in Cancer Research 10
Cancer Research top 1%
Molecular Biology top 2%
Hepatology top 5%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 22
Genetics
- Virus-based gene therapy research 9

Co-authors: H. Kim Lyerly Michael A. Morse Timothy M. Clay Amy Hobeika Hirokazu Nagawa Nelson H. Tsuno Alain Delcayre Donna Niedzwiecki
Cited by: Immunology Oncology Cancer Research
Journals: Clinical Cancer Research (7 papers)Cancer Research (7 papers)Journal of Clinical Oncology (6 papers)
Partner nations: United States Japan United Kingdom

In The Last Decade

Takuya Osada

114 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Takuya Osada

Since Specialization

Citations

This map shows the geographic impact of Takuya Osada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Osada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Osada more than expected).

Fields of papers citing papers by Takuya Osada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Osada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Osada. The network helps show where Takuya Osada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Takuya Osada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takuya Osada Line = papers co-authored together Takuya Osada links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The use of histotripsy as intratumoral immunotherapy beyond tissue ablation—the rationale for exploring the immune effects of histotripsy International Journal of Hyperthermia ·Takuya Osada,Xiaoning Jiang,Yuhang Zhao,Mengyue Chen,Yang Xin,Huaiyu Wu,Howuk Kim,Jun Ren,Joshua C. Snyder,Pei Zhong,Michael A. Morse,H. Kim Lyerly	2023	6
2	Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors Communications Biology ·Zoltán Buczolich,Takuya Osada,Michael A. Morse,William R. Gwin,Matthew Rahtelli,Joshua C. Snyder,Xiaoyi Yang,司永兵,Márcio A. Diniz,Khaldon Bodoor,Philip F. Hughes,Timothy Haystead,H. Kim Lyerly	2020	18
3	Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study Clinical Cancer Research ·Erika J. Crosby,William R. Gwin,Kimberly Blackwell,P. Kelly Marcom,Serena Chang,Holden T. Maecker,Gloria Broadwater,Terry Hyslop,Sungjin Kim,André Rogatko,Veronica Lubkov,Joshua C. Snyder,Takuya Osada,Amy Hobeika,Michael A. Morse,H. Kim Lyerly,Zachary C. Hartman	2019	54
4	Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers Breast Cancer Research ·Takuya Osada,Zachary C. Hartman,Jun-Ping Wei,Gangjun Lei,Amy Hobeika,William R. Gwin,Márcio A. Diniz,Neil L. Spector,Timothy M. Clay,Wei Chen,Michael A. Morse,H. Kim Lyerly	2018	15
5	In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior Clinical Cancer Research ·Takuya Osada,Zoltán Buczolich,William R. Gwin,Michael A. Morse,Amy Hobeika,Brian W. Pogue,Zachary C. Hartman,Philip F. Hughes,Timothy Haystead,H. Kim Lyerly	2017	14
6	A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo ACS Chemical Biology ·JU Guangyu,Philip F. Hughes,David A. Alcorta,Takuya Osada,Aaron P. Smith,Juliane Totzke,David R. Loiselle,Pedro Azpitarte Iribar,Madhusudhana Gargesha,Debasish Roy,Jose Roques,David B. Darr,H. Kim Lyerly,Neil L. Spector,Timothy Haystead	2017	41
7	N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: Influence of isomeric substitution on radiolabeling and target cell residualization Nuclear Medicine and Biology ·Jae‐Yeon Choi,Ganesan Vaidyanathan,Eftychia Koumarianou,Darryl McDougald,Marek Pruszyński,Takuya Osada,Tony Lahoutte,H. Kim Lyerly,Michael R. Zalutsky	2014	17
8	An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models Breast Cancer Research ·Wenle Xia,T. G. Rankine,Sumin Zhao,Lei-Hua Liu,Takuya Osada,Qing Cheng,Julia Wulfkuhle,William R. Gwin,Xiaoyi Yang,Rosa I. Gallagher,Sarah Bacus,H. Kim Lyerly,Neil L. Spector	2013	113
9	Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer Molecular Cancer Therapeutics ·Chengyong Xiao,Takuya Osada,William T. Barry,Xiao Yang,Jennifer A. Freedman,Àngels Carrió Lluch,Michael Datto,Bryan M. Clary,Timothy Clay,Michael A. Morse,Philip G. Febbo,H. Kim Lyerly,David S. Hsu	2012	31
10	Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion Journal of Translational Medicine ·Erika Hamilton,Kimberly Blackwell,Amy Hobeika,Timothy M. Clay,Gloria Broadwater,Xiu-Rong Ren,Wei Chen,Henry Castro,Frédéric Lehmann,Neil L. Spector,Jun-Ping Wei,Takuya Osada,H. Kim Lyerly	2012	78
11	Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients Clinical Cancer Research ·Michael A. Morse,Robert Chapman,John D. Powderly,Kimberly Blackwell,Tibor Keler,Jennifer Green,Abhi Kumar Singh,O. I. Ryabenko,Venky Ramakrishna,Laura Vitale,Biwei Zhao,Stephen A. Butler,Amy Hobeika,Takuya Osada,Thomas A. Davis,Timothy Clay,H. Kim Lyerly	2011	112
12	Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations Cancer Research ·Takuya Osada,Minyong Chen,Xiao Yang,Ivan Spasojević,Jeffrey VanDeusen,David S. Hsu,Bryan M. Clary,Timothy M. Clay,Wei Chen,Michael A. Morse,H. Kim Lyerly	2011	221
13	HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis Cancer Research ·Zachary C. Hartman,Xiaoyi Yang,Oliver Glass,Gangjun Lei,Takuya Osada,Sandeep S. Davé,Michael A. Morse,Timothy M. Clay,H. Kim Lyerly	2011	111
14	Ligand-Independent Toll-like Receptor Signals Generated by Ectopic Overexpression of MyD88 Generate Local and Systemic Antitumor Immunity Cancer Research ·Zachary C. Hartman,Takuya Osada,Oliver Glass,Xiao Yang,Gangjun Lei,H. Kim Lyerly,Timothy M. Clay	2010	32
15	An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity Clinical Cancer Research ·Zachary C. Hartman,Jun-Ping Wei,Takuya Osada,Oliver Glass,Gangjun Lei,P. R. Zellner,V L Muzykant,Dong‐Wan Kim,Wenle Xia,Neil L. Spector,Jeffrey R. Marks,William T. Barry,Amy Hobeika,Gayathri R. Devi,Andrea Amalfitano,Michael A. Morse,H. Kim Lyerly,Timothy M. Clay	2010	21
16	Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo International Journal of Cancer ·Michael A. Morse,Jun-Ping Wei,Zachary C. Hartman,Wenle Xia,Michal Drori,Gangjun Lei,William T. Barry,Takuya Osada,Amy Hobeika,V L Muzykant,Haixiang Jiang,Gayathri R. Devi,Wei Chen,Neil L. Spector,Andrea Amalfitano,H. Kim Lyerly,Timothy M. Clay	2009	19
17	Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody British Journal of Cancer ·Takuya Osada,David S. Hsu,Scott A. Hammond,Amy Hobeika,Gayathri R. Devi,Timothy M. Clay,H. Kim Lyerly,Michael A. Morse	2009	61
18	Epigallocatechin gallate affects human dendritic cell differentiation and maturation Journal of Allergy and Clinical Immunology ·Satomi Yoneyama,Kazushige Kawai,Nelson H. Tsuno,Yurai Okaji,Masahiro Asakage,Takeshi Tsuchiya,Jun Yamada,Eiji Sunami,Takuya Osada,Joji Kitayama,Koki Takahashi,Hirokazu Nagawa	2007	56
19	Adenovirus-human HER2 vaccine inhibits breast cancer growth and vaccine induced antibodies (VIA) are efficacious against Herceptin-refractory human breast cancer (48.32) The Journal of Immunology ·Jun-Ping Wei,نرگس احمدی فرد,Takuya Osada,Xiao Yang,Gangjun Lei,Haixiang Jiang,Gabriel T. Chong,Andrea Amalfitano,H. Kim Lyerly,Michael A. Morse,Timothy Clay	2007	1
20	α-Glycosylceramides Enhance the Antitumor Cytotoxicity of Hepatic Lymphocytes Obtained from Cancer Patients by Activating CD3−CD56+ NK Cells In Vitro The Journal of Immunology ·Soichiro Ishihara,Mie Nieda,Joji Kitayama,Takuya Osada,Toshio Yabe,Akiko Kikuchi,Yasuhiko Koezuka,Steven A. Porcelli,Kenji Tadokoro,Hirokazu Nagawa,Takeo Juji	2000	43

About Takuya Osada

Takuya Osada is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Cancer Research, having authored 117 papers that have together received 5.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (42 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), Immune Cell Function and Interaction (20 papers), Cancer Immunotherapy and Biomarkers (16 papers), T-cell and B-cell Immunology (14 papers), CAR-T cell therapy research (12 papers), HER2/EGFR in Cancer Research (10 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (2.0k citations), Cancer Research (1.1k citations), Molecular Biology (2.7k citations) and Hepatology (202 citations). Takuya Osada has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include H. Kim Lyerly, Michael A. Morse, Timothy M. Clay, Amy Hobeika, Hirokazu Nagawa, Nelson H. Tsuno, Alain Delcayre, Donna Niedzwiecki, Jean‐Bernard Le Pecq and Joji Kitayama. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Journal of Clinical Oncology, Cancer Immunology Immunotherapy and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact